The BMJ has released the names of an outside expert panel who will decide the fate of two articles that are the subject of a heated dispute. As previously reported, last week the BMJ published a correction to two papers published last year, explaining that both papers had  inaccurately overstated the incidence of the adverse effects of statins. However, a…

Click here to continue reading…